The prospective study looked at 77 patients undergoing ALIF procedures with the device. Independent radiologists analyzed the 138 spine segment levels treated, and found a 100 percent fusion rate between 6 and 12 months, according to the release.
The Endoskeleton implant uses a proprietary acid-etched surface to support bone purchase and new bone growth.
More Articles on Devices:
Medtronic to Recruit 323 Patients for Back Pain Treatment Clinical Trial
Medical Device Purchase: 3 Statistics on Physician Influence
FDA Increases Stryker Knee Device Recall to Class 1
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
